Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicity-Reference-Cited by-同舟云学术

Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicity

Published:2011-08-27 Issue:3 Volume:64 Page:249-265
ISSN:0920-9069
Container-title:Cytotechnology
language:en
Short-container-title:Cytotechnology

Author:

Konno Yoshinobu,Kobayashi Yuki,Takahashi Ken,Takahashi Eiji,Sakae Shinji,Wakitani Masako,Yamano Kazuya,Suzawa Toshiyuki,Yano Keiichi,Ohta Toshio,Koike Masamichi,Wakamatsu Kaori,Hosoi Shinji

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Biomedical Engineering,Bioengineering,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s10616-011-9377-2.pdf

Reference75 articles.

1. Abu-Absi SF, Yang L, Thompson P, Jiang C, Kandula S, Schilling B, Shukla AA (2010) Defining process design space for monoclonal antibody cell culture. Biotechnol Bioeng 106:894–905

2. Arathoon W, Birch J (1986) Large-scale cell culture in biotechnology. Science 232:1390–1395

3. Becker DJ, Lowe JB (2003) Fucose: biosynthesis and biological function in mammals. Glycobiology 13:41R–53R

4. Borys MC, Dalal NG, Abu-Absi NR, Khattak SF, Jing Y, Xing Z, Li ZJ (2010) Effects of culture conditions on N-glycolylneuraminic acid (Neu5Gc) content of a recombinant fusion protein produced in CHO cells. Biotechnol Bioeng 105:1048–1057

5. Burnouf T (2011) Recombinant plasma proteins. Vox Sang 100:68–83

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for controlling afucosylation in monoclonal antibodies during upstream manufacturing;Biotechnology Journal;2023-04-19

2. Microchip electrophoresis separation coupled to mass spectrometry (MCE–MS) for the rapid monitoring of multiple quality attributes of monoclonal antibodies;ELECTROPHORESIS;2022-09-22

3. Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD;Neurotherapeutics;2022-03-10

4. Characterization of Monoclonal Antibody Glycan Heterogeneity Using Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry;Frontiers in Bioengineering and Biotechnology;2022-01-11

5. Ublituximab: A Novel Anti-CD20 Therapy for Multiple Sclerosis;US Neurology;2022